Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study

Fig. 1

RPA-generated risk stratification for the RT alone in training set (A) and comparisons between the good-prognosis and poor-prognosis groups in the training set (B) and the testing set (C). RPA = recursive partitioning analysis; NPC = nasopharyngeal carcinoma; EBV = Epstein–Barr virus; HR = hazard ratio; CI = confidence interval; OS = overall survival

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us